Avalo Therapeutics, Inc.
(NASDAQ : AVTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.03%61.940.0%$779.50m
VRXValeant Pharmaceuticals International, Inc. -2.07%28.8614.1%$169.82m
CTLTCatalent, Inc. 0.28%141.412.0%$168.28m
PRGOPerrigo Co. Plc 0.55%43.016.9%$140.02m
ICLRICON plc 0.56%283.042.8%$122.12m
HZNPHorizon Therapeutics Plc 0.80%110.375.5%$106.97m
JAZZJazz Pharmaceuticals Plc 0.63%135.352.1%$104.94m
INDPIndaptus Therapeutics, Inc. -6.86%8.820.0%$101.49m
ARGXargenx SE -3.15%308.000.0%$64.03m
BHCBausch Health Cos., Inc. -2.07%28.860.0%$60.89m
ENDPEndo International Plc -3.85%3.258.5%$56.03m
UTHRUnited Therapeutics Corp. -2.68%195.1014.0%$46.59m
AXSMAxsome Therapeutics, Inc. 1.34%33.401.8%$38.98m
IRWDIronwood Pharmaceuticals, Inc. 3.54%13.459.5%$24.56m
SAGESAGE Therapeutics, Inc. -1.69%45.427.6%$21.56m

Company Profile

Avalo Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.